A nationwide recall has been issued for a blood‑thinner medication after testing revealed the presence of steel, cellulose and other foreign matter in the product batches. The recall, announced on October 19, 2026, covers all affected shipments across the United States due to the safety risk posed by the contamination.
Health authorities released a public‑health recall notice outlining the issue and advising patients and providers to discontinue use of the medication until further guidance is provided.